US stops production of AstraZeneca vaccines at Baltimore plant: Report

The US government stopped a Baltimore manufacturing plant that destroyed 15 million doses of Johnson & Johnson’s Covid-19 vaccine by having the vaccine developed by AstraZeneca Plc, the New York Times report.
J&J said in a statement that it “accepts full responsibility for the manufacture of medicines for the Covid-19 vaccine at the Bayview plant for Emergent BioSolutions Inc.”
It did not specify whether it would take over the plant. The company did not respond to Reuters’ requests for comment.
The New York Times reported AstraZeneca said in a statement that it would work with President Joe Biden’s administration to find an alternative site. The drug manufacturer did not respond to a request for comment.
The move by the U.S. Department of Health and Human Services will dedicate the Emergent BioSolutions facility solely to making the Johnson & Johnson vaccine, and according to the newspaper report, which cites two quotes, to avoid future blends. senior federal health official
The U.S. government’s leading doctor for infectious diseases has told Reuters that the country may not need the AstraZeneca vaccine, even if it gets it well.

.Source